Brian T Hill Selected Research

brexucabtagene autoleucel

6/2022	Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study.
1/2021	Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma.
1/2020	KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian T Hill Research Topics

Disease

21	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2021 - 09/2011
19	Neoplasms (Cancer) 01/2022 - 09/2011
18	B-Cell Lymphoma (Lymphoma, B Cell) 10/2022 - 01/2016
17	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2021 - 03/2011
14	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2022 - 06/2011
12	Lymphoma (Lymphomas) 10/2022 - 10/2013
9	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2019 - 01/2016
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 10/2013
5	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 09/2007
4	Leukemia 12/2021 - 12/2017
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 04/2010
3	Tumor Lysis Syndrome 01/2019 - 11/2017
2	Hairy Cell Leukemia 05/2022 - 12/2017
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021 - 05/2017
2	Disease Progression 04/2021 - 01/2020
2	Body Weight (Weight, Body) 01/2020 - 12/2017
2	Multiple Myeloma 01/2019 - 01/2016
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 02/2015
2	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 11/2017
1	Cytokine Release Syndrome 10/2022
1	Residual Neoplasm 06/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021
1	Progressive Multifocal Leukoencephalopathy 04/2021
1	Brain Diseases (Brain Disorder) 04/2021
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2021
1	B-Cell Leukemia (Leukemia, B Cell) 11/2020
1	Chromosome Deletion (Deletion, Chromosome) 01/2019
1	Sepsis (Septicemia) 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Wound Infection (Wound Infections) 01/2018
1	Atrial Fibrillation 11/2017
1	Hemorrhage 11/2017
1	Bronchiolitis Obliterans Syndrome 05/2017

Drug/Important Bio-Agent (IBA)

14	Rituximab (Mabthera)FDA Link 05/2022 - 01/2016
10	Chimeric Antigen ReceptorsIBA 10/2022 - 12/2017
8	venetoclaxIBA 11/2020 - 07/2015
7	axicabtagene ciloleucelIBA 10/2022 - 12/2017
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 06/2011
5	Proteins (Proteins, Gene)FDA Link 11/2020 - 09/2011
4	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021 - 01/2016
4	ibrutinibIBA 12/2019 - 11/2017
3	brexucabtagene autoleucelIBA 06/2022 - 01/2020
3	Bendamustine Hydrochloride FDA Link 01/2021 - 01/2019
3	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 01/2016
3	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 06/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 06/2011
3	Busulfan (Busulfex)FDA Link 01/2020 - 01/2016
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 06/2011
3	Bortezomib (Velcade)FDA Link 01/2019 - 01/2018
3	Phosphotransferases (Kinase)IBA 01/2018 - 07/2015
3	fludarabineIBA 12/2017 - 09/2014
3	idelalisibIBA 11/2017 - 10/2013
2	Purine NucleosidesIBA 05/2022 - 12/2017
2	AntigensIBA 01/2022 - 01/2018
2	MicroRNAs (MicroRNA)IBA 11/2021 - 11/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 06/2011
2	Prednisone (Sone)FDA LinkGeneric 01/2020 - 01/2019
2	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 06/2011
2	purineIBA 12/2017 - 09/2014
2	ABT-737IBA 07/2015 - 09/2011
1	selinexorIBA 04/2021
1	polatuzumab vedotinIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Pharmaceutical PreparationsIBA 06/2020
1	Ifosfamide FDA LinkGeneric 01/2020
1	PlatinumIBA 01/2020
1	HLA-A Antigens (HLA-A)IBA 12/2019
1	HLA-B Antigens (HLA-B)IBA 12/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Cyclin D1IBA 01/2019
1	Lenalidomide (CC 5013)FDA Link 01/2019
1	AnthracyclinesIBA 01/2019
1	IceIBA 04/2018
1	rasburicase (Elitek)FDA Link 01/2018
1	Everolimus FDA Link 01/2018
1	Saline SolutionIBA 01/2018
1	Allopurinol (Remid)FDA LinkGeneric 01/2018
1	Pentostatin (Nipent)FDA LinkGeneric 12/2017
1	Cladribine FDA LinkGeneric 12/2017
1	CI 22IBA 05/2017
1	Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA 01/2016
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2016
1	AntibodiesIBA 01/2016
1	spebrutinibIBA 01/2016
1	Cyclin EIBA 07/2015
1	dinaciclibIBA 07/2015

Therapy/Procedure

36	Therapeutics 01/2022 - 04/2010
13	Cell Transplantation 12/2021 - 02/2015
10	Drug Therapy (Chemotherapy) 01/2022 - 03/2011
9	Stem Cell Transplantation 01/2022 - 09/2007
4	Transplantation 01/2021 - 09/2007
3	Hematopoietic Stem Cell Transplantation 01/2018 - 04/2010
2	Immunotherapy 01/2021 - 01/2019
2	Homologous Transplantation 01/2018 - 09/2007
2	Radiotherapy 11/2017 - 04/2016
1	Autologous Transplantation 01/2018
1	Induction Chemotherapy 01/2018
1	Aftercare (After-Treatment) 12/2017